臨床進度
Preclinical PRE | Phase I PH I | Phase II PH II | Phase III PH III | ||
---|---|---|---|---|---|
Oncology US FDA IND 133158 | |||||
Infectious Disease US FDA IND 149841 | |||||
Neurodegenerative Disease |
Preclinical PRE | Phase I PH I | Phase II PH II | Phase III PH III | ||
---|---|---|---|---|---|
Oncology US FDA IND 133158 | |||||
Infectious Disease US FDA IND 149841 | |||||
Neurodegenerative Disease |